1 / 3

Preclinical Research and Development_ An Essential Stage for Drug Development (2)

Veeda Clinical Research Limited provides end-to-end drug development services to its global clients specialized in Pharmaceuticals, biopharmaceuticals, agrochemicals, Herbal, Nutraceuticals and Medical Devices.

Download Presentation

Preclinical Research and Development_ An Essential Stage for Drug Development (2)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Preclinical Research and Development: An Essential Stage for Drug Development Introduction: Preclinical research and development is a critical stage in the development of new drugs. This stage involves laboratory and animal testing of a new drug candidate to assess its safety, efficacy, and potential for toxic effects. The purpose of preclinical research is to identify potential issues and risks before the drug is tested in humans and to determine if the drug is suitable for further development. Why is Preclinical Research Important? Preclinical research is a crucial step in the drug development process, as it provides critical information on the safety and efficacy of a new drug candidate. The information gathered in preclinical studies is used to inform the design of clinical trials and to make decisions about whether the drug should be further developed. If a drug is found to be unsafe or ineffective in preclinical studies, it is unlikely to be developed further, saving valuable time and resources.

  2. What Happens During Preclinical Research and Development? Preclinical research and development typically begin with in vitro (in the laboratory) studies, which evaluate the drug's safety, pharmacokinetics (how the drug is absorbed, distributed, metabolized, and excreted), and pharmacodynamics (how the drug affects the body). The results of in vitro studies inform the design of in vivo (in living organisms) studies, which typically involve animal testing. Animal testing is an essential part of preclinical research and development, as it provides information on the drug's efficacy and potential toxic effects. Animal studies are conducted to determine the drug's dose-response relationship, evaluate its safety profile, and identify any possible toxic effects. The results of animal studies are then used to inform the design of clinical trials in humans. What Are the Benefits of Preclinical Research and Development? Preclinical research and development provide numerous benefits to the drug development process, including:

  3. Information on safety and efficacy: Preclinical research provides critical information on the safety and efficacy of a new drug candidate, allowing researchers to make informed decisions about whether the drug should be further developed. Time and cost savings: By identifying potential issues and risks in preclinical studies, researchers can avoid costly and time-consuming clinical trials that may not be feasible or successful. Better clinical trial design: The information gathered in preclinical studies is used to inform the design of clinical trials, making them more efficient and effective. Conclusion: Preclinical research and development is an important stage in the drug development process, providing critical information on a new drug candidate's safety, efficacy, and potential toxic effects. By conducting thorough preclinical studies, researchers can make informed decisions about whether a drug is suitable for further development and avoid costly and time-consuming clinical trials that may not be feasible or successful.

More Related